🔍 RecallPedia

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Class I - Dangerous
💊 Drugs Recalled: April 9, 2013 Aurobindo Pharma USA Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Aurobindo Pharma USA Inc
Reason for Recall:
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Product Codes/Lot Numbers:

Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-498-2013

Related Recalls